Skip to main content

Dr. Bach is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Bach's full profile

Already have an account?

  • Office

    2140 Bayberry Ln
    Scotch Plains, NJ 07076
    Phone+1 908-578-3634

Summary

  • Specializing in global pharmaceutical development, with a focus on Asia.

Education & Training

  • National Institutes of Health Clinical Center/Eunice Kennedy Shriver NICHD
    National Institutes of Health Clinical Center/Eunice Kennedy Shriver NICHDFellowship, Pediatric Endocrinology, 1988 - 1992
  • Baylor College of Medicine (Houston)
    Baylor College of Medicine (Houston)Residency, Pediatrics, 1985 - 1988
  • Baylor College of Medicine
    Baylor College of MedicineClass of 1985

Certifications & Licensure

  • NJ State Medical License
    NJ State Medical License 1993 - 2025
  • MD State Medical License
    MD State Medical License 1988 - 1994
  • TX State Medical License
    TX State Medical License 1986 - 1991

Press Mentions

  • Structure Therapeutics Initiates Phase 2a Study of Oral GLP-1 Agonist GSBR-1290 for the Treatment of Type 2 Diabetes and Obesity
    Structure Therapeutics Initiates Phase 2a Study of Oral GLP-1 Agonist GSBR-1290 for the Treatment of Type 2 Diabetes and ObesityMay 25th, 2023
  • Lumos Pharma Appoints Pediatric Endocrinologist Experienced in Clinical Research and Pharmaceutical Development, Mark Bach, M.D., Ph.D., to Clinical Scientific Advisory Board
    Lumos Pharma Appoints Pediatric Endocrinologist Experienced in Clinical Research and Pharmaceutical Development, Mark Bach, M.D., Ph.D., to Clinical Scientific Advisory BoardJuly 26th, 2021
  • Ascendis Pharma A/S Announces Presentations for TransCon™ hGH at Upcoming Medical Conferences
    Ascendis Pharma A/S Announces Presentations for TransCon™ hGH at Upcoming Medical ConferencesApril 21st, 2021
  • Join now to see all

Professional Memberships